Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia.
Publication
, Journal Article
Lee, KL; Ko, TK; Saw, NYL; Javed, A; Hillmer, AM; Chuah, C; Krishnan, V; Ong, ST
Published in: Leukemia
March 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Leukemia
DOI
EISSN
1476-5551
Publication Date
March 2022
Volume
36
Issue
3
Start / End Page
892 / 896
Location
England
Related Subject Headings
- Transcriptome
- Mutation
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Immunology
- Humans
- Gene Expression Regulation, Leukemic
- Core Binding Factor Alpha 2 Subunit
- Blast Crisis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lee, K. L., Ko, T. K., Saw, N. Y. L., Javed, A., Hillmer, A. M., Chuah, C., … Ong, S. T. (2022). Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia. Leukemia, 36(3), 892–896. https://doi.org/10.1038/s41375-022-01508-1
Lee, Kian Leong, Tun Kiat Ko, Nicole Y. L. Saw, Asif Javed, Axel M. Hillmer, Charles Chuah, Vaidehi Krishnan, and S Tiong Ong. “Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia.” Leukemia 36, no. 3 (March 2022): 892–96. https://doi.org/10.1038/s41375-022-01508-1.
Lee KL, Ko TK, Saw NYL, Javed A, Hillmer AM, Chuah C, et al. Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia. Leukemia. 2022 Mar;36(3):892–6.
Lee, Kian Leong, et al. “Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia.” Leukemia, vol. 36, no. 3, Mar. 2022, pp. 892–96. Pubmed, doi:10.1038/s41375-022-01508-1.
Lee KL, Ko TK, Saw NYL, Javed A, Hillmer AM, Chuah C, Krishnan V, Ong ST. Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia. Leukemia. 2022 Mar;36(3):892–896.
Published In
Leukemia
DOI
EISSN
1476-5551
Publication Date
March 2022
Volume
36
Issue
3
Start / End Page
892 / 896
Location
England
Related Subject Headings
- Transcriptome
- Mutation
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Immunology
- Humans
- Gene Expression Regulation, Leukemic
- Core Binding Factor Alpha 2 Subunit
- Blast Crisis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences